Should You Invest in Gold Now? Prices Near ₹1 Lakh

Invest in Gold: Gold prices have been rising sharply in 2025, hitting record highs both in India and globally. In India, gold futures on the MCX (Multi Commodity Exchange) touched ₹95,935 per 10 grams, while in international markets, gold went up to $3,371.90 per ounce. However, some profit booking caused a slight dip later, with prices closing at ₹95,239.

Invest in Gold:
So far this year, gold has gained around 25%. This sharp increase is mainly due to global uncertainties, geopolitical tensions, and expectations that the US Federal Reserve will cut interest rates. Central banks around the world, especially in countries like India and China, have also been buying large amounts of gold, pushing prices higher.

One major reason for this rise is the unstable global economy. Issues like trade conflicts and political unrest make gold a safer investment for many. When the economy is uncertain, people and governments tend to invest more in gold to protect their wealth.

Experts believe that although the current price is high, it may not touch ₹1,00,000 per 10 grams immediately. Anuj Gupta of HDFC Securities says gold might reach ₹97,000 in the short term but the ₹1 lakh mark could take until late 2025 or early 2026 depending on global economic trends.

Renisha Chainani from Augmont highlights that gold is still expected to stay strong in the coming months due to ongoing inflation concerns and central bank strategies to reduce their reliance on the US dollar. But without fresh global shocks or triggers, the pace of growth might slow down.

So, what should investors do? Experts suggest staying balanced. If you already hold a lot of gold, it might be a good time to take some profit. If you have little or no gold in your portfolio, buying gradually during price dips could be wise. Diversifying between gold and silver may also help reduce risk while offering growth opportunities.

In conclusion while gold is performing well in 2025, short-term movements are uncertain. Long-term prospects still look positive, especially if economic uncertainties continue. But investors should make decisions based on their risk tolerance and financial goals.

Also Read: Indian pharma enters $145 billion US oncology market against FDA